ESC 365 - The impact of spironolactone in heart failure with mid-range ejection fraction: a future therapeutic tool?

ACVC Premium Access

The impact of spironolactone in heart failure with mid-range ejection fraction: a future therapeutic tool?

Session: Poster Session 2 - Acute Heart Failure: Pharmacotherapy

Topic: Pharmacotherapy

Speaker: Doctor M. Pires (Viseu, PT)

Event: Acute Cardiovascular Care 2019

Congress Presentation

About the speaker

Doctor Maria Ines Pires

Hospital Sao Teotonio, Viseu (Portugal)

0 follower

3 more presentations in this session

Efficacy of tolvaptan in treating patients with heart failure with the preserved ejection fraction

Speaker: Doctor Y. Suzuki (Nagoya, JP)

Levosimendan versus dobutamine in cardiogenic shock. A real alternative?

Speaker: Doctor M. Corbi Pascual (Albacete, ES)

Prognostic impact of nitrate use in acute heart failure

Speaker: Mr J. Lopes (Coimbra, PT)

Access the full session

Poster Session 2 - Acute Heart Failure: Pharmacotherapy

Speakers: Doctor M. Pires, Doctor Y. Suzuki, Doctor M. Corbi Pascual, Mr J. Lopes

About the event

Acute Cardiovascular Care 2019

2 March - 4 March 2019

Sessions Presentations

Congress

ESC 365 is supported by